Tech Company Financing Transactions

Tricida Funding Round

Tricida secured a $55 million Series C investment round on 7/26/2016. Investors included Longitude Capital Management, Limulus Venture Partners and OrbiMed.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

7000 Shoreline Ct. 201
South San Francisco, CA 94080
USA

Phone

(415) 429-7800

Website

www.tricida.com

Email Address

[email protected]

Overview

Tricida, Inc. is an innovative startup company focused on the discovery and clinical development of novel therapeutics to address renal, metabolic and cardiovascular disease.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Gerrit Klaerner

        

Chief Financial Officer

Geoffrey Parker

        

Chief Technical Officer

Wilhelm Stahl

        

Vice President

Dawn Parsell

        

VP - Bus. Development

Claire Lockey

        

VP - General Counsel

Edward Hejlek

        

Browse more venture capital transactions:

Prev: 7/26/2016: Sansoro Health venture capital transaction
Next: 7/26/2016: Transfix venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary